CoreFirst Bank & Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$926K Sell
2,633
-270
-9% -$96.3K 0.49% 47
2025
Q4
$950K Buy
2,903
+115
+4% +$36.5K 0.51% 44
2025
Q3
$787K Buy
2,788
+10
+0.4% +$2.9K 0.43% 53
2025
Q2
$776K Buy
2,778
+255
+10% +$72.2K 0.44% 54
2025
Q1
$786K Buy
2,523
+280
+12% +$82.7K 0.51% 50
2024
Q4
$585K Buy
2,243
+7
+0.3% +$2.08K 0.35% 65
2024
Q3
$720K Sell
2,236
-50
-2% -$16.4K 0.42% 55
2024
Q2
$714K Sell
2,286
-155
-6% -$45.5K 0.48% 52
2024
Q1
$694K Sell
2,441
-198
-8% -$57.9K 0.43% 54
2023
Q4
$760K Sell
2,639
-55
-2% -$15K 0.51% 48
2023
Q3
$724K Sell
2,694
-90
-3% -$22.5K 0.51% 50
2023
Q2
$618K Sell
2,784
-18
-0.6% -$4.18K 0.44% 54
2023
Q1
$677K Sell
2,802
-265
-9% -$65K 0.49% 50
2022
Q4
$806K Sell
3,067
-270
-8% -$72.4K 0.61% 39
2022
Q3
$752K Sell
3,337
-580
-15% -$141K 0.65% 35
2022
Q2
$953K Sell
3,917
-487
-11% -$119K 0.75% 29
2022
Q1
$1.06M Sell
4,404
-533
-11% -$122K 0.73% 32
2021
Q4
$1.11M Sell
4,937
-696
-12% -$147K 0.72% 28
2021
Q3
$1.2M Sell
5,633
-336
-6% -$77.3K 0.83% 24
2021
Q2
$1.46M Sell
5,969
-557
-9% -$137K 0.99% 22
2021
Q1
$1.62M Buy
6,526
+3,075
+89% +$734K 1.12% 19
2020
Q4
$793K Buy
+3,451
New +$796K 0.59% 39

Other funds holding AMGN

CoreFirst Bank & Trust's AMGN Position: Q1 2026 in Review

CoreFirst Bank & Trust reduced its Amgen (AMGN) stake by 9.3% in Q1 2026, selling an estimated $96.3K and leaving 2,633 shares worth $926K. The position accounts for 0.49% of the portfolio, ranked #47.

CoreFirst Bank & Trust first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.62M in Q1 2021. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • CoreFirst Bank & Trust held 2,633 shares of Amgen worth $926K as of Q1 2026.
  • CoreFirst Bank & Trust sold 270 Amgen shares in Q1 2026, an estimated $96.3K.
  • Amgen made up 0.49% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #47 holding.
  • CoreFirst Bank & Trust first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • CoreFirst Bank & Trust's Amgen position peaked at $1.62M in Q1 2021.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.